Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
- 8-K - CG Oncology, Inc. (0001991792) (Filer)
CG Oncology, Inc. submitted a Form 8-K on August 6, 2026 (Accession No. 0001193125-26-336886), containing Item 2.02 results of operations and financial condition, Item 8.01 other events, and Item 9.01 financial statements and exhibits.
- 8-K - Arteris, Inc. (0001667011) (Filer)
Arteris, Inc. filed a Form 8-K on August 6, 2026, reporting departures and appointments of directors and officers, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Vystar Corp (0001308027) (Filer)
Vystar Corp filed an 8-K reporting entry into a material definitive agreement, completion of an acquisition or asset disposition, unregistered sales of equity securities, and accompanying financial statements and exhibits.
- 8-K - MAXIMUS, INC. (0001032220) (Filer)
Maximus Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including financial statements and related exhibits. The filing, accession number 0001032220-26-000033, is 661 KB.
- 8-K - ONCOR ELECTRIC DELIVERY CO LLC (0001193311) (Filer)
Oncor Electric Delivery Co LLC filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.
- 8-K - Ensysce Biosciences, Inc. (0001716947) (Filer)
Ensysce Biosciences filed an 8-K reporting entry into a material definitive agreement, completion of an asset acquisition/disposition, unregistered equity sales, modifications to security holder rights, changes in directors/officers and compensation, and amendments to its charter and fiscal year.
- 8-K - Annexon, Inc. (0001528115) (Filer)
Annexon, Inc. filed a Form 8-K on August 6, 2026, reporting other events under Item 8.01 and providing its financial statements and related exhibits under Item 9.01.
- 8-K - CRA INTERNATIONAL, INC. (0001053706) (Filer)
CRA International, Inc. filed a Form 8-K on August 6, 2026, reporting results of operations and financial condition, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Corbus Pharmaceuticals Holdings, Inc. (0001595097) (Filer)
Corbus Pharmaceuticals Holdings filed a Form 8-K on August 6, 2026, containing Item 2.02 (results of operations and financial condition), Item 7.01 (Regulation FD disclosure), and Item 9.01 (financial statements and exhibits).
- 8-K - Vivani Medical, Inc. (0001266806) (Filer)
Vivani Medical, Inc. filed a Form 8-K on August 6, 2026, containing a Regulation FD disclosure and accompanying financial statements and related exhibits.
- 8-K - HELIX ENERGY SOLUTIONS GROUP INC (0000866829) (Filer)
Helix Energy Solutions Group Inc filed a Form 8-K on August 6 2026, including Item 2.02 results of operations and financial condition, Item 7.01 Regulation FD disclosure, and Item 9.01 financial statements and exhibits.
- 8-K - Edgewise Therapeutics, Inc. (0001710072) (Filer)
Edgewise Therapeutics filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - VivoSim Labs, INC. (0001497253) (Filer)
VivoSim Labs, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - ALX ONCOLOGY HOLDINGS INC (0001810182) (Filer)
ALX Oncology Holdings Inc filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - LIFETIME BRANDS, INC (0000874396) (Filer)
Lifetime Brands filed an 8-K on August 6, 2026, reporting its results of operations and financial condition and including financial statements and related exhibits.
- 8-K - ESTABLISHMENT LABS HOLDINGS INC. (0001688757) (Filer)
Establishment Labs Holdings Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 reporting its results of operations and financial condition, and Item 9.01 containing its financial statements and related exhibits.
- 8-K - ACI WORLDWIDE, INC. (0000935036) (Filer)
ACI Worldwide, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition, providing a Regulation FD disclosure, and attaching financial statements and related exhibits.
- 8-K - MBX Biosciences, Inc. (0001776111) (Filer)
MBX Biosciences, Inc. filed an 8-K on August 6, 2026, containing Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits).
- 8-K - INSIGHT ENTERPRISES INC (0000932696) (Filer)
Insight Enterprises Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing financial statements and related exhibits.
- 8-K - NOVAVAX INC (0001000694) (Filer)
Novavax Inc. filed a Form 8-K on August 6, 2026, including Item 2.02 covering its results of operations and financial condition and Item 9.01 containing its financial statements and related exhibits.
- 8-K - Aurinia Pharmaceuticals Inc. (0001600620) (Filer)
Aurinia Pharmaceuticals filed a Form 8-K on August 6, 2026, including Item 2.02 on results of operations and financial condition and Item 9.01 containing financial statements and exhibits.
- 8-K - Prime Medicine, Inc. (0001894562) (Filer)
Prime Medicine, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing financial statements and related exhibits (Item 9.01).
- 8-K - Globalstar, Inc. (0001366868) (Filer)
Globalstar, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - USA TODAY Co., Inc. (0001579684) (Filer)
USA TODAY Co., Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing related financial statements and exhibits.
- 8-K - HERTZ CORP (0000047129) (Filer)
Hertz Corp filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and including its financial statements and related exhibits.
- 8-K - HERTZ GLOBAL HOLDINGS, INC (0001657853) (Filer)
Hertz Global Holdings, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.
- 8-K - NextTrip, Inc. (0000788611) (Filer)
NextTrip, Inc. filed a Form 8-K on August 6, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - Playtika Holding Corp. (0001828016) (Filer)
Playtika Holding Corp. filed a Form 8-K on August 6, 2026, reporting its results of operations, financial condition, and providing financial statements and related exhibits.
- 8-K - Guerrilla RF, Inc. (0001832487) (Filer)
Guerrilla RF, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition (Item 2.02) and providing its financial statements and related exhibits (Item 9.01).
- 8-K - Aligos Therapeutics, Inc. (0001799448) (Filer)
Aligos Therapeutics, Inc. filed a Form 8-K on August 6, 2026, reporting its results of operations and financial condition and providing its financial statements and related exhibits.